medical research abu dhabi

The Biotechnology Research Center (BRC) utilizes recent advances in molecular, cellular and digital technologies to develop human expertise and biotech. We address various challenges in advanced biorobotics and environmental applications while enabling better healthcare outcomes through molecular and genomics strategies, as well as AI enhanced bioinformatics and biomedicine.

BRC is part of the  Technology Innovation Institute (TII) , a global scientific research center attracting the world’s foremost scientists and researchers. TII leads worldwide advances in artificial intelligence, autonomous robotics, quantum computing, cryptography and quantum communications, directed energy, secure communication, smart devices, advanced materials, and propulsion and space technologies, and biotechnology fields.

TII belongs to the Abu Dhabi Government’s  Advanced Technology Research Council (ATRC) , which oversees the technology research in the emirate.

We harness the power of cutting-edge advancements in molecular, cellular, and digital technologies to shape the future of human expertise and biotechnology. In addition, we are enhancing healthcare outcomes by seamlessly integrating molecular and genomic strategies with the precision of AI-augmented bioinformatics and biomedicine.

Bio-medicine

Bio-Robotics and Nano

Environmental Biotech

Molecular Biotech and Genomics

Bio-informatics

ASPIRE Precision Medicine Research Institute *Abu Dhabi

Welcome to APMAD, the world's leading Virtual Research Institute dedicated to pioneering breakthroughs in biotechnology. At the heart of Abu Dhabi's scientific advancement, we are transforming the future of healthcare. Our research focuses on key areas: cancer, brain health, metabolic and genetic disorders. APMAD is more than an institute, it's a hub where innovative thinking meets practical solutions, where talent thrives, and where every discovery contributes to a healthier, brighter future. From seasoned scientists to budding researchers, from investors to healthcare professionals, APMAD is where you shape the future of medicine.

* ASPIRE Precision Medicine Abu Dhabi – Virtual Research Institute

Your Gateway to Revolutionary Biotechnology - Embrace the Future with Us

At APMAD, we are opening new horizons in Abu Dhabi's biotech landscape, ensuring sustainable health improvements through precision medicine. We welcome you to explore:

Our Themes:

News & Stories

Space Biomedicine Webinar

Brain Health Workshop

Seminar: The Convergence of Social Media Analytics and Health Research

ASPIRE PMRIAD End-of-Year Meeting: A Look Back and Forward

Dive into our journey as a virtual research institute, dedicated to pushing the boundaries of science and knowledge.

Explore our focused research areas: genetics, metabolics, brain health, and cancer, as we unravel the mysteries of each domain.

Reach out to connect, collaborate, or inquire about our groundbreaking research endeavors.

Our partner institutions

Abu Dhabi opens new clinical trials unit to boost medical research

The new unit will conduct research and trials focused on key disease areas

Abu Dhabi has inaugurated a new clinical trials unit to help respond to pressing local health challenges and position the emirate as a research and innovation hub.

The new unit was launched by Sheikh Shakhbout Medical City (SSMC), a joint-venture partnership between Mayo Clinic and Abu Dhabi Health Services Company (SEHA).

to enabling the health sector in the expansion of research and development. The newly launched Clinical Trials Unit, brings medical research and development to the forefront in finding innovative solutions to the treatment of patients with complex care requirements. pic.twitter.com/Qfx8LtQsOZ — Sheikh Shakhbout Medical City (@SSMCAbuDhabi) January 17, 2023

The centre will conduct complex research and trials focused on key disease areas like neurology, rheumatology, hematology, oncology, cardiology, ophthalmology, gastroenterology and pediatrics.

SSMC’s researchers will also collaborate with national research institutions across the country, including hospitals and universities.

Meanwhile, the unit will offer greater opportunities for local and regional researchers, helping to develop the next generation of doctors aspiring to pursue medical research, a statement said.

The launch of the trials unit is part of a multi-phase approach, spread over a period of 10 years. The unit’s core infrastructure and initial operations will be established within the first two years of operations, marking its first phase. Phase 2 will see the creation of a dedicated physical space.

H.E. Sheikh Abdulla bin Mohamed Al Hamed, H.E. Dr. Jamal Al Kaabi, Dr. Naser Ammash, chief executive officer at #SSMC , cut the ribbon at the opening ceremony of the Clinical Trials Unit. pic.twitter.com/MKJtqqCJQ2 — Sheikh Shakhbout Medical City (@SSMCAbuDhabi) January 17, 2023

The unit, in its third phase, will reach its innovation development capabilities, including business development and entrepreneurship.

“The groundbreaking launch of our clinical trials unit illustrates our commitment to investing in research and finding new and innovative ways to treat our patients and respond to the region’s most concerning health challenges today and in the future,” said Dr Naser Ammash, chief executive officer of SSMC.

“SSMC’s clinical trials unit is a foundational component of what we’re building to become a leading medical research institute in the region performing unparalleled translational research at the interface of medicine, science, and technology,” added Dr. Shahrukh Hashmi, acting medical director of research at SSMC.

“At this moment in time, we have over 55 industry and investigator-initiated trials and over 30 registries that are ongoing or in development.”

Meanwhile, Dr Asma Al Mannaei, executive director of the research and innovation center at the Department of Health – Abu Dhabi (DoH), noted that currently, there were around 400 clinical research trials under way in Abu Dhabi.

Abu Dhabi has been home to research and innovative medical projects. In July of last year, the Abu Dhabi Early Childhood Authority (ECA) had announced Dhs1.2m worth of funding for five research projects related to early childhood development (ECD).

Read:  Abu Dhabi Early Childhood Authority awards Dhs1.2m to fund research projects

G42 Healthcare signed a strategic agreement with US-based ProPhase Precision Medicine to explore collaborative opportunities focusing on, but not limited to, genomic sequencing, artificial intelligence, sharing genomic data insights, and obtaining advanced certifications.

Read:  G42 Healthcare, ProPhase to collaborate on genomic sequencing capabilities, data insights

Also read:  Role of biotechnology and life sciences in UAE’s healthcare ambitions

In early 2021, the UAE had launched a project to begin manufacturing the Covid-19 vaccine within the country.

Read:  UAE to begin manufacturing ‘Hayat-Vax’ Covid-19 vaccine

You might also like

UAE real estate: Over 30,000 residential units to be delivered by year’s end

Mubadala Capital’s $3bn Fortress bid clears key US regulatory hurdle: FT reports

Etihad’s Q1 profit soars to Dhs526m ahead of potential IPO

Aldar issues second $500m green sukuk

Every 51st resident in dubai is a millionaire, reveals world’s wealthiest cities report, abu dhabi pilots mena’s first passenger-carrying drone flights, gulf business may 2024 roundup: mastercard, supercar blondie and more, latest issue.

• Saudi Arabia
• Real Estate
• Special Report
• Art & Culture

Advertise With Us

Privacy policy.

© 2021 MOTIVATE MEDIA GROUP. ALL RIGHTS RESERVED.

• Environment
• Road to Net Zero
• Art & Design
• Film & TV
• Music & On-stage
• Pop Culture
• Fashion & Beauty
• Home & Garden
• Things to do
• Combat Sports
• Horse Racing
• Beyond the Headlines
• Trending Middle East
• Business Extra
• Culture Bites
• Year of Elections
• Pocketful of Dirhams
• Books of My Life
• Iraq: 20 Years On

Abu Dhabi launches grant programme to promote research and innovation in healthcare

Funding will support clinical research projects that have the potential to fight rare diseases, cancer, alzheimer's and other ailments.

The Department of Health has teamed up with the emirate's healthcare sector, government and non-government entities in the UAE to offer a grant that will support clinical research. AFP

Abu Dhabi has launched a new programme of funding aimed at supporting research and innovation to fight life-threatening diseases.

The emirate's Department of Health said the grant will be offered to those who carry out clinical research projects in the areas of cardio-metabolic and vascular disorders, cancer , Alzheimer's disease , rare diseases, emerging infectious disease and antimicrobial resistance .

It is also open to people who have innovative technological ideas and solutions focusing on smart hospitals and the prevention and management of chronic diseases, a news release said.

The winners will also receive guidance to ensure project continuity and sustainability.

Applicants can submit their entries on www.doh.gov.ae but they should partner with a healthcare facility in Abu Dhabi to finalise and submit their entries.

Applications will be accepted during the next six weeks but the grant amount has not been revealed.

A committee of experts from the Department of Health - Abu Dhabi (DoH) and Abu Dhabi Health Research & Technology Committee will evaluate and assess submissions. It will be headed by Dr Asma Al Mannaei, executive director of the research and innovation centre at the DoH.

"As part of the DoH’s efforts to [support] the capital’s position as a leading destination for life sciences and innovation, we are committed to enabling and empowering innovators and researchers within our community to take their passion projects to the next stage," she said.

"With Abu Dhabi providing the right environment for individuals and companies to thrive, we are thrilled to put forward this grant that will expand clinical research capabilities in the emirate as well as conceptualise unique projects in the capital.

“We look forward to receiving and reading through all entries as well as providing guidance to all applicants. This is an exciting milestone for the healthcare sector that will spread a fine share of healthy competition among science and technology fanatics.”

To offer the grant, DoH has partnered with the emirate's healthcare sector, government and non-government entities in the UAE.

Abu Dhabi aims to become a destination of choice for clinical trials and collaborative healthcare research.

The emirate has ambitions to capture the world's first population-wide genetic library, pioneer connected health and build on previous collaborations with pharmaceutical giants Pfizer and AstraZeneca in medical research.

Last year, G42 Healthcare launched Insights Research Organisation and Solutions, a first-of-its-kind contract research organisation in the UAE to support internationally leading standards of scientific and ethical research, conduct clinical trials and report and develop treatments.

The company was started following the success of the country’s Phase III clinical trials for the development and testing of a Covid-19 vaccine, where 130 nationalities participated.

In March, the capital partnered with Pfizer to train and support 150 Abu Dhabi scientists to conduct clinical research at the level required by multinational companies to produce effective medicines.

Abu Dhabi charts a futuristic path in healthcare - in pictures

Emiratis in the UAE have been urged to voluntarily give an anonymous blood sample to help expand the data collection for the Emirati Genome Project. All photos by Khushnum Bhandari / The National

• Employee Self Service

Change Color

• Our Priorities
• Laws & Legislations
• Centre of Excellence
• Organ Donation
• Primary Care
• Medical Education
• Coronavirus - COVID -19
• Medical Tourism

Research and Innovation Center

• Professionals
• Abu Dhabi Health Workforce Masterplan
• Scope of Practice
• Lists & Tools
• Medications & Supplements Awareness Material
• Jawda - Quality Metrics
• Unified Healthcare Professional Qualification Requirements (PQR)
• Health Information Exchange standards

Healthcare facilities are required to complete the Training Programme on Abu Dhabi Healthcare Guidelines for Health Media & Advertising System as mentioned in circular number 26/2023, for more information Click Here

DOH urges all healthcare and pharmaceutical facilities & Health professional to Adhere to the circular number(63\2021) by updating the details of the mobile number & e-mail address in order to receive all circulars & letters issued by DOH, for more information Click Here

Research and Innovation Programs

Through our programs DOH ensures that safe and effective drugs are available to improve the health of the people in Abu Dhabi.

Real World Data/Evidence Research

Real-world data are data relating to patient health status and/or the delivery of health care routinely collected from a variety of sources, such as electronic health records, administrative claims and medical product/device registries. Research conducted using real world data can generate real world evidence to support regulatory, clinical and reimbursement decisions and to encourage further research.

Below are reports on RWD research projects: Note: The perspectives and viewpoints presented in these reports are those of the authors and do not represent the official policies or stances of the Department of Health Abu Dhabi (DOH).

• Spinal Muscular Atrophy Disease

For more information on RWD/RWE research, please contact: [email protected]

Restrictions on Dispensing of Selected Broad Spectrum Antimicrobials

Reference to circulars number 135/2021 and 31/2022 regarding restrictions on dispensing of selected broad spectrum antimicrobials, below are the updated annex 1 list and exempted outpatient pharmacies lists: Updated Annex 1: List of antibiotics for Outpatient Pharmacies (updated 31 Jan 2022)

Exempted Outpatient Pharmacies (updated 16 th Jan 2024)

ANTIMICROBIAL STEWARDSHEIP PROGRAM

• The increasing antimicrobial resistance is imposing scientific, economic, governance and societal challenges endangering public health worldwide.  Coordinated approach at global, regional, local, community and even at institutional level is much needed.
• Antimicrobials are in general overused/ misused in healthcare facilities. DOH is more concerned about broad-spectrum antibiotics misuse for minor outpatient conditions. Overuse/ misuse of antimicrobials is resulting in increasing antibiotic resistance limiting treatment options.
• DOH requires all hospitals and day surgery centers in the Emirate of Abu Dhabi to establish a functional Antimicrobial stewardship program

Antimicrobial Stewardship Program (ASP)

• ASP represents a multidisciplinary coordinated programmatic effort that promotes the optimal selection of antimicrobial treatment, dosage and duration that results in the best possible clinical outcome for the treatment or prevention of infection, with minimal toxicity to the patient and minimal impact on the subsequent antibiotic resistance profile. 
• Effective implementation of ASP requires strong commitment, investment and resource allocation from hospital management that would support the business case of antimicrobial stewardship.  It also entails training of key staff members, in addition to the development of appropriate processes and supporting systems.  
• DOH has adopted multi-faceted, coordinated comprehensive strategy to curb the increasing antimicrobial resistance. The main objectives of DOH ASP Program are as below

GS1 Barcoding of Drugs

Harmonizing with Global Standards

• GS1 - a global standard of barcoding offers the functionalities and solutions to strengthen drug supply chains.  Full implementation of GS1 barcoding system will enable us to monitor drug supplies and take corrective actions to minimize supply interruptions, having quality products available, prevent entry of counterfeit drugs and reduce unnecessary higher drug cost.
• GS1 standards are being adopted by most countries. Several Gulf countries are actively working towards full implementation of GS1 barcoding requirements.

The main objectives of the GS1 Barcoding are:

• Streamlining drug supply and enhancing efficiency, transparency and reliability
• Implementing unified GS1 barcoding on drugs used along the entire supply chain
• Centralize tracking of drug supplies - Utilize barcode scanning to obtain drug supply information through digital portal for better planning and appropriate actions
• Oversight inventory management of drugs supplied to AD emirate
• Address/ mitigate weaknesses in drug supply (minimize drug shortages and supply interruptions)
• Develop drug supply database for future analyses
• Support DoH Digital Health Strategy
• Enhance patient safety across the Emirate of Abu Dhabi

Actions Taken

• DoH Chairman decree 39/2020 issued on 21st July 2020 to mandate GS1 barcoding on pharmaceuticals
• Stakeholder consultation meetings held with stakeholders: MOHAP & DHA, CCAD, SEHA, RAFED, Pharma Manufacturing companies, Drug stores and suppliers.
• Created DOH account on (GS1 database)
• Monitoring the implementation and performance of companies on BrandSync

Subscribe for updates

Thanks for subscribing, last updated: 14 may 2024.

• Refer a Patient
• Our Leadership
• CEO Message
• Facts and Figures
• Awards and Accreditations
• Annual Reports
• Corporate and Community Outreach
• Appointments
• Executive Health Program
• International Patient Services
• Patient Stories
• Visiting Guidelines
• How to get to SSMC
• Child Safety Survey
• Patient Education
• Health Blogs
• Our Doctors
• Adolescent Medicine
• General Pediatrics
• Pediatric Endocrinology
• Pediatric Intensive Care
• Pediatric Neurology
• Pediatric Rheumatology
• Pediatrics Neonatology
• General surgery
• Neurosurgery
• Ophthalmology
• Oral and Maxillofacial Surgery (OMF)
• Orthopedics
• Otolaryngology – Head and Neck Surgery (ENT)
• Pediatric Surgery and Pediatric Urology
• Plastic and Reconstructive Surgery
• Thoracic Surgery
• Vascular Surgery
• Dermatology
• Endocrinology
• Gastroenterology and Hepatology
• Internal Medicine
• Physical Medicine and Rehabilitation
• Pulmonary and Sleep Medicine
• Rheumatology
• Tropical and Infectious Diseases
• Department of Pathology and Laboratory
• Department of Critical Care
• Department of Emergency Medicine
• Department of Clinical Imaging
• Department of Obstetrics and Gynecology
• Department of Anesthesiology
• Department of Radiation Therapy
• Introduction to Education
• Graduate Medical Education Center
• Simulation Center
• Nursing Education Center
• Medical Student Education Center
• Health Sciences Education Center
• Staff Development Center
• Clinical Trials Unit
• Scientific Advisory Committee
• Institutional Review Board (IRB)
• Request an Appointment

Jan. 18, 2023

Sheikh shakhbout medical city inaugurates a dedicated clinical trials unit.

• In partnership with Mayo Clinic, SSMC opens a dedicated Clinical Trials Unit to set a new benchmark for innovative research and development in the UAE
• The inauguration comes in line with DoH’s ongoing efforts to enable the healthcare sector to expand R&D operations in the Emirate and elevate the sector’s outcomes
• SSMC’s Clinical Trials Unit will conduct complex research and trials focused on key disease areas like Neurology, Cardiology and Oncology

Sheikh Shakhbout Medical City (SSMC), one of the UAE’s largest hospitals for serious and complex care and a joint-venture partnership between Mayo Clinic and Abu Dhabi Health Services Company (SEHA), launched today one of the most advanced Clinical Trials Units in Abu Dhabi. By conducting research on areas with unmet medical needs, the Unit will help the UAE respond to pressing local health challenges, contributing to a more sustainable health care system and supporting the ongoing efforts to position Abu Dhabi as a leading life-science research and innovation hub.

In the presence of H.E. Abdulla bin Mohamed Al Hamed, Chairman of the Department of Health – Abu Dhabi (DoH), a delegation from the Department witnessed the inauguration, including H.E. Dr. Jamal Al Kaabi, Undersecretary of DoH.

The newly inaugurated specialist Unit will be led by a dedicated team of researchers set to conduct cutting-edge research and complex trials to help reduce the impact of some of the greatest health care challenges in Neurology, Rheumatology, Hematology, Oncology, Cardiology, Ophthalmology, Gastroenterology and Pediatrics. SSMC’s researchers will also collaborate with national research institutions across the country, including hospitals and universities in the UAE.

H.E Dr. Jamal Al Kaabi, Undersecretary of the Department of Health, said: “Under the directives of the UAE’s wise leadership, we are proud to witness Sheikh Shakhbout Medical City lead the way of complex research and trials from the heart of Abu Dhabi. Supported by the Department of Health, the inauguration comes in line with DoH’s ongoing efforts to enable the healthcare sector to expand R&D operations in the Emirate and elevate the sector’s outcomes. Reinforcing Abu Dhabi’s position as a leading destination for life sciences, we are confident that this milestone will fruit innovative solutions and expose insights to some of the most pressing healthcare challenges.”

Through localizing research, SSMC’s team of researchers will be able to address the immediate and future needs of the UAE’s population and help optimize processes and standards when it comes to delivering care. Looking towards the future, the Unit is also set to provide greater opportunities for local and regional researchers, helping to develop the next generation of doctors aspiring to pursue medical research.

Dr. Naser Ammash , Chief Executive Officer of SSMC, said: “As part of SSMC’s three shield vision with clinical practice, research and education being interlocked disciplines working together to find definitive solutions to unmet patients’ needs, research is a fundamental pillar that brings new discoveries to the bedside and adds value to the local health care ecosystem. The groundbreaking launch of our Clinical Trials Unit illustrates our commitment to investing in research and finding new and innovative ways to treat our patients and respond to the region’s most concerning health challenges today and in the future. This would not be possible without our partnership with Abu Dhabi’s Department of Health and Mayo Clinic.”

Dr. Shahrukh Hashmi , Acting Medical Director of Research at SSMC, said: “Research is a distinguishing element for Mayo Clinic, and here at SSMC, we share that commitment to solving complex research questions for the benefit of our patients. SSMC’s Clinical Trials Unit is a foundational component of what we’re building to become a leading medical research institute in the region performing unparalleled translational research at the interface of medicine, science, and technology. We are extremely proud to have the specialized infrastructure for complex trials and research to address key healthcare areas right here at the hospital. At this moment in time, we have over 55 industry and investigator-initiated trials and over 30 registries that are ongoing or in development.”

Dr. Asma Al Mannaei, Executive Director of the Research and Innovation Center at the Department of Health – Abu Dhabi (DoH), said: “Inspired by the UAE’s visionary leadership, Abu Dhabi is primed to be a major clinical trial capital and our healthcare ambitions are limitless. We are proud to witness leading healthcare bodies such as Sheikh Shakhbout Medical City excel in the field of research and clinical trials, further solidifying the Emirate’s position as a leading destination for life sciences. Currently, there are around 400 clinical research trials under way in Abu Dhabi, and we are confident the newly inaugurated unit will further elevate efforts and accelerate findings and innovative solutions.”

With Abu Dhabi’s visionary leadership fully supporting SSMC’s Clinical Trials Unit to conduct innovative medical research, SSMC is one step closer to meeting patients’ complex care needs. SSMC will continue leveraging SEHA’s long-standing legacy, understanding of local demands, and Mayo Clinic’s expertise and extensive medical experience.

The launch of SSMC’s Clinical Trials Unit is part of a multi-phase approach, which sets the center on a 10-year growth course. In the first phase, the Unit’s core infrastructure and initial operations will be established within the first two years of operations. Phase 2 will see the creation of a dedicated physical space, and finally in a third phase, the Unit will reach its mature innovation development capabilities, including business development and entrepreneurship.

May 7, 2024

Sheikh shakhbout medical city performs bile duct injury repair using robotic surgery.

April 25, 2024

Sheikh shakhbout medical city team successfully removes 30.5kg ovarian tumor.

April 23, 2024

Uae president recognizes ssmc doctor among honorees at abu dhabi awards 2024.

March 6, 2024

Transformation expo – 2024.

• Request an appointment

Care of the Critically Ill Surgical Patient (CCrISP) is a two-day, interactive course, which includes mandatory, pre-course e-learning. It covers the practical skills and knowledge that health care professionals need to effectively care for surgical patients, including those who are deteriorating or at risk of doing so.

• Webmail (Office 365)
• Banner Student Registration
• ADERP – [Off Campus]
• ADERP – [On Campus]
• MFA Self-Service
• Future Students
• Prospective Bachelors
• Prospective Masters & PhD
• Equipment Directory
• Business Development
• Procurement & Contracts

• Undergraduate Admissions
• Postgraduate Admissions

Scholarships

• College of Engineering and Physical Sciences
• College of Computing and Mathematical Sciences
• College of Medicine And Health Sciences
• Academic Calendar
• General Education Unit
• Center for Teaching and Learning (CTL)
• Cyber Security Academy
• Undergraduate
• Postgraduate
• Continuing Education Department
• Accreditation
• Body Museum
• Khazna – Institutional Repository
• University Research Council
• Research Offices
• R&D Facilities
• Research Centers
• Technology, Management & Innovation
• Research Groups & Labs
• Student Council
• Clubs and Association
• Student Events & Programs
• Getting Around
• Resident Life
• Career And Alumni Services
• Student Success
• Events Calendar
• Brand Guidelines
• Newsletters and Publications
• Exhibitions and Conferences
• Achievements & Rankings
• Provost Office
• Research & Development Office
• Ethics & Compliance
• Living in Abu Dhabi
• Partnerships and Initiatives
• Environment heath and safety campus
• Sustainability
• Organizational Chart
• ISO Certificates

• Khazna – Institutional Repository
• Civil Security Unit
• Research Projects
• Clubs & Associations
• Pre-Medicine Bridge
• Doctor Of Medicine (M.D.)

College of Medicine and Health Sciences

Academic Departments and Special Programs

Dean’s Message

Departments and special programs, office of student affairs.

Dear Members of the College of Medicine and Health Sciences Community,

It is with great pleasure that I extend a warm welcome to you on behalf of the College of Medicine and Health Sciences at Khalifa University.

I am delighted to share with you the exciting developments and future trajectory of our esteemed College. We are undergoing a transformative journey that involves a strategic shift in our academic programs, reflecting our commitment to staying at the forefront of healthcare education and research.

I am privileged to announce an exciting expansion of our College, marked by the establishment of four distinct departments. These departments represent a commitment to excellence in education, research, and innovation across a spectrum of disciplines—from the advancement of biological sciences to groundbreaking innovations at the intersection of bioengineering and biotechnology, dedicated efforts in epidemiology and public health, and specialized education in medical science.

Aligned with our vision for the future of healthcare and medicine, these focused departments will not only pave the way for groundbreaking advancements but will also introduce advanced degree programs. As a significant enhancement, I am pleased to announce the introduction of Masters and Ph.D. programs, offering students opportunities for in-depth research, specialization, and advanced training.

As we embark on this exciting journey, your enthusiasm, expertise, and dedication are integral to our success. We look forward to your active engagement as we work together to make a lasting impact on the field of health and life sciences.

Thank you for being a crucial part of the College of Medicine and Health Sciences at Khalifa University. I encourage you to explore the unique programs we offer and discover how we can support you in achieving your academic and professional aspirations.

Professor Habiba Al Safar

Dean, College of Medicine and Health Sciences

Director, Biotechnology Center

Professor at the Biomedical Engineering Department

At the College of Medicine and Health Sciences at Khalifa University, our overarching vision is to be a global leader in transformative education, innovative research, and healthcare excellence. We envision a dynamic academic community that inspires a lifelong passion for learning, producing healthcare professionals known for their exceptional skills, compassion, and commitment to advancing healthcare on both local and global fronts.

Our commitment to cutting-edge research and interdisciplinary collaboration positions us at the forefront of medical and health sciences. We aspire to shape the future of medicine, address the evolving needs of diverse communities, and contribute significantly to healthcare advancements. Beyond traditional education, we foster a culture of innovation, resilience, and social responsibility, striving to build a healthier and more equitable world.

Grounded in a commitment to excellence, integrity, and the continuous pursuit of knowledge, our vision positions the College of Medicine and Health Sciences at Khalifa University as a beacon of innovation, a hub for transformative education, and a driving force behind the advancement of healthcare for generations to come

To cultivate a transformative learning ecosystem that seamlessly integrates academic excellence, fosters cutting-edge research and innovations in healthcare, develops exceptionally skilled healthcare professionals, and plays an active role in enhancing the health and the well-being of our local and global communities.

• To be a global leader in transformative education, cultivating a dynamic learning environment that inspires a lifelong passion for healthcare, producing highly skilled professionals dedicated to advancing medical knowledge and patient care.
• To be a pioneering research hub, expanding our portfolio to encompass cutting-edge disciplines and innovative healthcare technologies
• Foster a culture of innovation, resilience, and social responsibility, in synergy with the Abu Dhabi hospital ecosystem.

The college aims to accomplish its mission through commitment to the following core values:

• Excellence: We are committed to maintaining the highest standards of academic and research excellence, fostering an environment where continuous improvement is embraced across all facets of education, healthcare, and research.
• Integrity: We uphold the principles of honesty, transparency, and ethical conduct in all our endeavors, fostering a culture of trust and accountability within our academic community and in our interactions with the broader society.
• Innovation: We embrace a spirit of creativity and innovation, encouraging exploration and the pursuit of groundbreaking ideas that contribute to advancements in healthcare, medical research, and the broader fields of health and life sciences.
• Diversity and Inclusion: We celebrate diversity in all its forms, fostering an inclusive and supportive environment that values and respects the unique perspectives, backgrounds, and contributions of every individual within our community.
• Collaboration: We believe in the power of collaboration and interdisciplinary approaches, actively seeking partnerships with academic institutions, healthcare organizations, and industry leaders to amplify the impact of our research and education initiatives.
• Social Responsibility: We are dedicated to making a positive impact on society by addressing healthcare disparities, promoting public health, and instilling a sense of social responsibility in our students, faculty, and staff.
• Lifelong Learning: We promote a culture of lifelong learning, recognizing that education is a continuous journey. We encourage curiosity, adaptability, and a commitment to staying at the forefront of knowledge and skills in the ever-evolving landscape of health and life sciences.
• Community Engagement: We actively engage with our local and global communities, understanding that our success is intertwined with the well-being of the broader society. Through community partnerships, outreach programs, and service initiatives, we seek to contribute meaningfully to societal development.

These core values guide our actions, decisions, and interactions, shaping the character of the College of Medicine and Health Sciences at Khalifa University.

Departments

Special Programs

Doctor of Medicine (MD) Program

The 4-year course of study leading to the doctor of medicine (M.D.) degree employs a variety of educational strategies, including problem based learning and clinical experiences to enable students to gain the competencies expected of all physicians. Additionally, the program offers an emphasis on providing technology-enhanced healthcare in service to the community. The program prepares students for postgraduate study in any specialty, for licensure, and for future medical practice. It incorporates innovative curricular design that promotes scientific inquiry, critical thinking and comprehensive clinical expertise. Overall, the program evolves medical education in such a way as to prepare physicians for the next 20 years and beyond

The program goals of the MD program are to:

• Provide an integrated clinical and research experience in a singular postgraduate level medical education program;
• Educate and inspire a diverse workforce of physicians who understand the needs of patients, are able to communicate across cultures, and collaborate with diverse teams;
• Prepare physicians who are able to seamlessly integrate technology into personalized preventative medical practice;
• Prepare medical students and residents to serve as specialty physicians to practice evidence-based medicine in the healthcare and hospital systems of Abu Dhabi and the United Arab Emirates;
• Attract and retain a diverse and talented faculty dedicated to providing outstanding medical education and supporting the professional development of medical students;
• Respond to stakeholder and government needs for medical education leading to clinicians who can serve the healthcare needs of the United Arab Emirates; and
• Be an essential contributor to the development, enhancement and completion of the existing healthcare ecosystem of Abu Dhabi.

The four-year course of study leading to the Doctor of Medicine degree at Khalifa University is based on development of competencies across ten domains. These competencies provide a summary of what graduates of the program are expected to demonstrate in the workplace after graduation, as residents, fellows, and clinical practitioners. They are based on the needs of the program’s constituencies. The ten domains are:

• Patient care (CD1)
• Knowledge for practice (CD2)
• Practice-based learning and improvement (CD3)
• Interpersonal and communication skills (CD4)
• Professionalism (CD5)
• Systems-based practice (CD6)
• Inter-professional collaboration (CD7)
• Personal and professional development (CD8)
• Technology enhanced healthcare (CD9)
• Social Accountability (CD10)

Entrustable Professional Activities (EPAs) for Entering Residency provide expectations for both learners and teachers that include 13 activities all medical students should be able to perform upon entering residency, regardless of their future career specialty. EPAs offer a practical approach to assessing competence in real-world settings. During your time as a student, your competency in performing the EPAs is documented in an e-portfolio that can be shared with residency directors to provide clear demonstration that you can successfully perform the activities required for entrance into residency. The 13 core EPAS are:

• EPA 1 Gather a history and perform a physical examination.
• EPA 2 Prioritize a differential diagnosis following a clinical encounter.
• EPA 3 Recommend and interpret common diagnostic and screening tests.
• EPA 4 Enter and discuss orders and prescriptions.
• EPA 5 Document a clinical encounter in the patient record.
• EPA 6 Provide an oral presentation of a clinical encounter.
• EPA 7 Form clinical questions and retrieve evidence to advance patient care.
• EPA 8 Give or receive a patient handover to transition care responsibility.
• EPA 9 Collaborate as a member of an inter-professional team.
• EPA 10 Recognize a patient requiring urgent or emergent care and initiate evaluation and management.
• EPA 11 Obtain informed consent for tests and/or procedures.
• EPA 12 Perform general procedures of a physician.
• EPA 13 Identify system failures and contribute to a culture of safety and improvement.

Pre-Medicine Bridge Program1

1A Pre-Medicine Bridge program has been established to prepare students for the MD program.

The Pre-Medicine Bridge program is designed to provide courses to current students who have completed a Bachelor’s degree. The educational goals of the program are to prepare students for entry into Khalifa University’s Doctor of Medicine (MD) program.

The Pre-Medicine Bridge program consists of courses that are delivered in person by a lecturer or via on online facility. As each student attending the program will come with their unique skill set and knowledge, the courses are designed to fill gaps in information as well as develop reading, comprehension and math proficiencies. By developing these skills, the program will establish whether a candidate can demonstrate advanced knowledge, and in doing so, fulfill the requirements of entry into a postgraduate medical program. Students will be assessed using the Medical College Admission Test (MCAT®).

Entry into the Pre-Medicine Bridge program at Khalifa University will be based on the student’s performance at an interview and:

Completion of an undergraduate degree with prerequisite science, math or engineering content, achieving a minimum GPA of 3.0 from a preeminent institution of higher education. IELTS score of 6.5 (or equivalent) A personal statement. A recent copy of the applicant’s curriculum vitae. Three letters of support from professional and personal referees. At least one reference must be from a faculty member from the candidate’s conferring university.

This program offers scholarships to all students to support graduate studies in medicine. Students who receive a Khalifa University MED Scholarship will be registered in the Pre-Medicine Bridge program. Please note that scholarship benefits are subject to change.

• A monthly stipend of AED28,000.
• Full tuition to be paid by Khalifa University.
• Support to attend educational events locally and internationally.
• Housing in university accommodations at no cost, subject to availability.
• Textbooks are provided by the university.

Please click on the “Apply Now” button.

• For existing users, login to the application portal with your Email ID and password.
• For new users, register by creating a new account, by providing your Email as an ID and nominate your own password.

Khalifa University’s research portfolio currently includes medical genetics, biomaterials for nanomedicine, cellular biomechanics, bio-robotics, tissue regeneration, and bioinformatics. The university also has, and will continue to further develop, research capabilities and expertise with competencies in systems engineering, biomedical engineering, genome sciences and artificial intelligence (AI). Rapidly evolving technologies such as artificial intelligence (AI) and robotics are expected to play a significant role in the healthcare and medical sector in the next 10 years and remain a focus of the CMHS.

In consultation with external stakeholders and industry partners, the College of Medicine and Health Sciences ensures that its research and development programs are relevant to the biomedical, health and pharmaceutical sectors of the UAE and region. There are three established research centers that serve as hubs for a steady increase in research participation and productivity of CMHS faculty. These centers are 1) the Healthcare Engineering Innovation Center, 2) the Center for Autonomous Robotics Systems, and 3) the Center for Biotechnology.

Research News

• Book appointment
• Hospitals & Clinics
• Specialities
• Patient Portal

• Important notice

Mediclinic International is aware of a fake social media post that is being circulated requesting users to engage with a Medical Feedback Reward Survey. Mediclinic has not circulated any such survey. The social media post has not been published by Mediclinic. Mediclinic advises that people do not engage with the survey or respond. We release all our official communications on our website and our official social media channels .

• Mediclinic Middle East
• Stay Services & Hospitals - Mediclinic Middle East
• Clinics & Hospitals in Dubai & Abu Dhabi - Mediclinic
• Health Knowledge
• Services and Specialities
• Mediclinic Health Packages
• Careers at Mediclinic Middle East
• About Mediclinic Middle East
• Media and News
• Mediclinic Middle East - Referring Doctors
• Mediclinic Middle East - Careers at Mediclinic
• Mediclinic Baby - Prenatal, Maternity & Antenatal Care
• Privacy Statement
• Terms of Use
• Mediclinic Emergency
• Mediclinic Middle East - Health Insurance Partners
• What you should do in an emergency

Clinical Research in The Middle East - Mediclinic

• Mediclinic Middle East Special Offers
• Pharmacy Home Delivery
• Mediclinic Kids
• Mediclinic Middle East - Book an Appointment with Our Doctors
• Mediclinic Precise - Genetic Testing & Profiling
• Mediclinic at Home
• Bourn Hall Fertility Centre
• Ayadi Homecare, أيادي للرعاية الصحية المنزلية
• Quality healthcare services in the comfort of your home
• Patient Privacy Notice
• Health Experience Hub
• Client Experience Hub
• Mediclinic Hospitals and Clinics Ramadan timings - مواعيد عمل مستشفيات وعيادات ميديكلينيك خلال شهر رمضان المبارك
• Mediclinic Middle East International Nursing Conference
• Genetic Health

Mediclinic Middle East is one of the very few private healthcare organisations in the UAE to actively support its clinician’s research endeavours through medical research centres in the UAE. The number of facilities at Mediclinic Middle East provides access to a wide variety of patients and therapeutic areas. MCME has established a Research office to engage research opportunities that can substantially impact patients’ wellbeing. 

The Corporate Research Office is dedicated to the following:

• Ensure that all the research projects carried out at MCME are approved by the internal Research and Ethics Committee as well as the local Regulatory Authorities prior to initiation
• Contact point for Clinical Research Organisations and sponsors
• Provide support to the MCME research teams 
• Monitor and evaluate ongoing research
• Manage clinical research project budgets
• Provide Good Clinical Practice (GCP) training to MCME Research teams
• Ensure patient safety throughout all clinical trials 

MCME Research Brochure

PDF | 1.18 MB

Research Studies

Workflow Process

Mediclinic Middle East Research Office follows specific guidelines to ensure that clinical research is carried out ethically and adds real value to the scientific community.

Our Publications

Dr. Adrian Stanley Chief Academic Officer

Dr Rakshinda Mujeeb Research Projects Manager Rakshinda.Mujeeb@mediclinic.ae

Ms. Zineb Katache   Research Assistant Zineb.katache@mediclinic.ae

Mediclinic Middle East Research Office Mediclinic Corporate Office, Dubai Production City, Publishing Pavillion, Level 6, PO Box 123812, Dubai UAE. Contact Email:  MCME-ResearchOffice@mediclinic.ae

• Current Students
• Latest News
• Social Media Directory
• Search NYU Abu Dhabi

• Undergraduate
• Faculty Profiles
• Community Programs
• Academic Strategy
• Executive Education
• Strategic Philanthropy Initiative

• Research Institute Centers
• Faculty Labs and Projects
• Facilities and Support
• Postdoctoral Research

• Living in Abu Dhabi
• Undergraduate Experience
• Graduate Student Community
• Athletics and Fitness
• Student Stories
• Public Programs
• NYUAD at a Glance
• Inclusion, Diversity, Belonging, and Equity
• Leadership and Administration
• 19 Washington Square North
• Community Engagement
• Social Responsibility
• Work With Our Students
• Sustainability and Stewardship
• Contact and Location
• Past Events
• Emergency Alerts
• Open Enrollment Courses
• Global Sports Leadership Certificate

Public Health Research Center

The United Arab Emirates is confronting major public health challenges in tobacco use, obesity, diabetes, and cardiovascular disease. These factors have complex co-determinants in human genetic susceptibility and environmental conditions, ranging potentially from the built environment to the human microbial milieu (microbiome). The mission of the New York University Abu Dhabi Public Health Research Center (PHRC) is to improve the health of the population in the United Arab Emirates through scientific research.

Principal Goals

• To identify environmental and genetic determinants of health and of premature death, disease and disability in UAE.
• To develop and test novel public health interventions to promote wellness and reduce premature death, disease and disability in UAE.
• To create a world-class public health research center in Abu Dhabi and develop a cadre of highly skilled public health scientists and practitioners.

NYUAD PHRC focuses on addressing critical health topics for the UAE through these projects:

UAE Healthy Future Study As the first prospective cohort study in the United Arab Emirates, the UAE Healthy Future Study will provide unique and substantive evidence for both lifestyle and genetic determinants of common diseases in the UAE population.

Interventional Studies Research Examining the impact of evidence-based interventions to improve outcomes related to physical activity, diabetes, tobacco use cessation and exposure to secondhand smoke.

Dokha Tobacco Research Dokha tobacco is an alternative product that is endemic to the region, but has recently grown in appeal globally. The PHRC at NYUAD has convened a cadre of international experts in tobacco use to examine the biological, socio-behavioral, and clinical practice impacts of dokha tobacco.

Public Health Research Center P.O. Box 129188 Abu Dhabi, UAE

Email:  [email protected]

• Latest News
• Emergencies
• Ask the Law
• GN Fun Drive
• Visa+Immigration
• Phone+Internet
• Reader Queries
• Safety+Security
• Banking & Insurance
• Dubai Airshow
• Corporate Tax
• Top Destinations
• Corporate News
• Electronics
• Home and Kitchen
• Consumables
• Saving and Investment
• Budget Living
• Expert Columns
• Community Tips
• Cryptocurrency
• Cooking and Cuisines
• Guide to Cooking
• Art & People
• Friday Partner
• Daily Crossword
• Word Search
• Philippines
• Australia-New Zealand
• Corrections
• From the Editors
• Special Reports
• Pregnancy & Baby
• Learning & Play
• Child Health
• For Mums & Dads
• UAE Success Stories
• Live the Luxury
• Culture and History
• Staying Connected
• Entertainment
• Live Scores
• Point Table
• Top Scorers
• Photos & Videos
• Course Reviews
• Learn to Play
• South Indian
• Arab Celebs
• Health+Fitness
• Gitex Global 2023
• Best Of Bollywood
• Special Features
• Investing in the Future
• Know Plan Go
• Gratuity Calculator
• Notifications
• Prayer Times

AI in focus as first-ever Abu Dhabi Global Healthcare Week gets underway

Khaled bin Mohamed bin Zayed opens event’s debut edition, being held till May 15 at ADNEC

Abu Dhabi: The use of AI (artificial intelligence) in medical research is among key themes of the first-ever Abu Dhabi Global Healthcare Week (ADGHW), which started on Monday.

Get exclusive content with Gulf News WhatsApp channel

Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of Abu Dhabi Executive Council, inaugurated ADGHW, being organised by the Department of Health – Abu Dhabi under the theme ‘Accelerating the Future of Global Healthcare’, at Abu Dhabi National Exhibition Centre (ADNEC) till May 15.

During a tour of the exhibition, Sheikh Khaled was briefed on the latest innovations in healthcare technologies and developments in medical sciences being showcased by healthcare institutions and companies. He was accompanied by Sheikh Theyab bin Mohamed bin Zayed Al Nahyan, Deputy Chairman of the Presidential Court for Development and Fallen Heroes' Affairs.

The event is expected to attract 5,000 participants, including 1,000 delegates from participating countries, 100 exhibitors, and more than 250 expert speakers from around the world, who have gathered to exchange insights and discuss the latest scientific trends and technological initiatives in healthcare, including disease diagnostic systems, pharmaceutical manufacturing projects, and the development of genomics and hereditary disease research, among other areas.

Sheikh Khaled highlighted that the UAE’s efforts in the healthcare sector, including launching several initiatives, innovative projects and programmes, reflect the leadership’s vision to provide advanced healthcare by accelerating research in medical and therapeutic fields, and by investing in strengthening healthcare infrastructure, including hospitals, healthcare facilities and specialised laboratories, to help further enhance the community’s health and quality of life.

He emphasised that organising this global event reflects Abu Dhabi’s commitment to supporting and encouraging investment in research and development in healthcare and life sciences by reinforcing cooperation and strategic partnerships between the public and private sectors to accelerate the transition to a preventive healthcare ecosystem that uses the most advanced innovations, while further strengthening Abu Dhabi’s position as a leading global healthcare hub that attracts innovation and global talent.

During its first day, the event is hosting the Healthcare Leaders Forum, which will welcome around 200 VIPs including ministers and public officials, CEOs, international investors, heads of multilateral organisations, and leading health and medicine experts, to discuss ways of taking action to address current challenges in global healthcare. The results and recommendations of the forum will serve as a foundation for developing future strategic healthcare plans.

Meanwhile, the Future Health Summit will host a wide variety of panel sessions and live discussions around themes central to healthcare, including the use of AI in medical research, human longevity research, genomics, biotechnology, and pharmaceuticals, among other themes.

More From Health

GCAA take steps to control air travel diseases

Dubai: Legionella test result in 2 days instead of 14

New cohort of Emirati nurses joins frontline workforce

Complex heart transplant saves life of Emirati, 28

UAE: CBSE schools celebrate stellar Grade 10,12 results

After record rains, can AI predict flood impact in UAE?

Dubai Metro back on track after service disruption

Weather alert: Beware of foggy conditions in Abu Dhabi

Dubai marine transport to shift to summer timings

CBSE Grade 10, Grade 12 board exam results declared

Apple set to sell vision pro headset outside us, uae banks to help ‘genuine’ rain-hit cases: al ghurair, webcastle receives best e-commerce award - ksa in 2024, xcath to perform live telerobotic surgery model trial.

Get Breaking News Alerts From Gulf News

We’ll send you latest news updates through the day. You can manage them any time by clicking on the notification icon.

• Hi, My Account Subscriptions --> My KT Trading Contact Us Privacy Notice Sign Out

Tue, May 14, 2024 | Dhu al-Qadah 6, 1445

Dubai 20°C

• Expo City Dubai
• Emergencies
• Ras Al Khaimah
• Umm Al Quwain

Life and Living

• Visa & Immigration in UAE
• Banking in UAE
• Schooling in UAE
• Housing in UAE
• Ramadan 2024
• Saudi Arabia
• Philippines
• Cryptocurrency
• Infrastructure
• Currency Exchange
• Horse Racing
• Local Sports

Entertainment

• Local Events

Dubai World Cup

• Track Notes
• Big Numbers
• Daily Updates
• Arts & Culture
• Mental Health
• Relationships
• Staycations
• UAE Attractions
• Tech Reviews
• Motoring Reviews
• Movie Reviews
• Book reviews
• Restaurant Reviews
• Young Times

Supplements

• Back To School
• Eid-Al-Adha
• It’s Summer Time
• Leading Universities
• Higher Education
• India Real Estate Show
• Future Of Insurance
• KT Desert Drive
• New Age Finance & Accounting Summit
• Digital Health Forum
• Subscriptions
• UAE Holidays
• Year of the 50th
• Latest News
• Prayer Timings
• Cinema Listings
• Inspired Living
• Advertise With Us
• Privacy Notice

KT APPDOWNLOAD

Uae: region's largest hybrid cord blood bank launched in abu dhabi, the facility can safely preserve as many as 100,000 cord blood samples and five million pan-human samples.

Ashwani Kumar

• Follow us on

Embracing the bright side: A guide on how to cultivate optimism

The power of solitude: Why you should go on a solo trip

How to get your kids to read: Essential tips for parents

Published: Tue 14 May 2024, 9:49 AM

Last updated: Tue 14 May 2024, 11:23 AM

The Abu Dhabi Biobank has been launched with its first offering being the region’s largest hybrid cord blood bank. Located in M42's Omics Centre of Excellence, Masdar City, the biobank has state-of-the-art automated technology and best-of-its-kind large-capacity biobanking infrastructure.

The facility can safely preserve as many as 100,000 cord blood samples and five million pan-human samples, making it viable for research and therapeutic use for 30 years. The biobank will create a diverse dataset to provide ready and better-matched hemopoietic stem cells globally.

Cord blood is the remains in the umbilical cord after a baby's birth. It is usually discarded, but it is rich in stem cells and can be used to treat many diseases, blood-related disorders, illnesses, immune deficiencies, genetic disorders, and stem cell transplants.

Announced at the Abu Dhabi Global Healthcare Week, the initiative aims to shorten waiting times for treatment, improve survival rates, and create a diverse, foundational bio-asset that supports treatments of rare diseases, early detection and disease prevention, life science research for medical innovation, and novel drug discovery targets. It will strive to deliver the highest personalised, precise, high-quality, and preventative healthcare for all.

The initiative is part of Abu Dhabi's vision of building a unique global biobanking hub that delivers invaluable data assets with a maximal impact on people's health.

Dr Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi (DoH), noted the launch of the Abu Dhabi Biobank is poised to deliver biobanking excellence across the region.

"The wealth of biological and medical data amassed by the biobank will serve as a catalyst for scientific breakthroughs, expediting drug discovery, thus contributing to the emirate's ability to find solutions for local and global health challenges. It will significantly impact clinical care and patient outcomes, emphasising cord-derived stem cell therapies, and enable the delivery of local stem cell therapy delivery."

Facilities offering services

The service will be introduced across four leading healthcare entities dedicated to maternal and child health across Abu Dhabi. Prospective parents can avail themselves of this service at Danat Al Emarat Hospital for Women and Children, part of the M42 group, Corniche Hospital, Kanad Hospital, and hospitals as part of NMC Healthcare.

"The Abu Dhabi Biobank's ability to link cord blood, tissue, stem cells, and a wide range of normal and pathological human specimens with established large genomic, proteomics, and clinical records sets the scene for transformative and cutting-edge initiatives," Dr Al Ghaithi said.

Help in lifesaving treatment

The hybrid cord blood bank is part of the Abu Dhabi Biobank, which will include pan-human and tumour biobank in its next expansion phase. The cord blood bank will enable better care outcomes, build the nation's self-sufficiency in meeting the urgent need for cord blood stem cells, and further enhance regional capabilities in research and innovation. Stem cells work like a 'bio repair kit', helping to heal, restore, and replenish other cells that can be used to treat certain haematological and immune system disorders, like leukaemia, lymphoma, and bone marrow diseases requiring a transplant.

Ashish Koshy, group chief operating officer, M42, said: "The Abu Dhabi Biobank will foster global innovation in therapy development, as it holds huge potential for regenerative medicine, aiding in rare disease treatment, genetic screening, early detection, and scientific research."

The cord blood bank locally collects and preserves umbilical cord cells, offering donors the choice of preserving a newborn's stem cells at birth, for potentially lifesaving treatments, at no risk to them or their baby. Expectant mothers can preserve their baby's cord blood by opting for a completely safe, secure, painless, and non-intrusive process that can potentially save lives and help build a healthier nation. They will have the opportunity to preserve the stem cells as part of public or private banking.

Prospective parents can email [email protected], call 800 213, or visit www.m42.ae for more details.

• Abu Dhabi's new AI academy to boost healthcare workers' skills, improve patient care
• UAE witnesses surge in nursing course enrolments post-pandemic
• UAE firm to perform live telerobotic surgery trial at Abu Dhabi Global Healthcare Week
• [email protected]

More news from Lifestyle

Nurturing young minds: the power of preschool prep.

The essence of Preschool Prep lies in its harnessing the distinctive curiosity of children,

lifestyle 3 weeks ago -->

UAE-based public speaker on talking your way to the top

Arab-Canadian public speaking coach and author of The Million Dollar Speaker Maher Elusini on how to make your speech command value for time and money

Can children become great entrepreneurs?

Not every kid is meant to go to university or college. So, it makes sense to teach them entrepreneurial skills early

UAE: How this Dubai expat emerged as one of the most successful Bangladeshi entrepreneurs globally

The story of a non-resident Bangladeshi family establishing and running the famed perfume company Al Haramain and its successful subsidiaries

The ACT: A Great Alternative to the SAT

ACT is accepted by all US colleges and universities

UAE: This father-son duo defied stereotypes to become top dancers

UAE-based father-son duo Rahul and Bharat Gupta are pushing the boundaries of dance, one step at a time

lifestyle 1 month ago -->

Can lifestyle changes help in reversing the ageing process?

The month of fasting may be over, but it's still a good entry point into an anti-ageing lifestyle

Keeping it in the family: Love for technology and business compels US couple to make UAE their home

Their innate love for technology and business and the UAE's innovative business initiatives compel US couple to make the country their home

Type your keywords

• Latest News
• Year of Sustainability
• Abu Dhabi in a Week
• Arts & Culture
• Crown Prince
• Environment

Government Affairs

• Infrastructure
• Initiatives

Abu Dhabi Media Office - Copyright 2024

Popular search terms

• Mohamed bin Zayed
• Khaled bin Mohamed bin Zayed
• Department of Health – Abu Dhabi partners with M42 to launch largest hybrid cord blood bank

14 May 2024

Share this article

• Link Copied

The Department of Health – Abu Dhabi (DoH) and M42 have collaborated to launch the Abu Dhabi Biobank, with its first offering being the region’s largest hybrid cord blood bank. Reinforcing the emirate’s position as a leading destination for life sciences, the initiative aims to shorten waiting times for treatment, increase therapeutic access for patients, improve survival rates and reduce the economic burden on governments.

Announced at the inaugural Abu Dhabi Global Healthcare Week 2024, where M42 is participating as the Foundation Partner, the Abu Dhabi Biobank is part of the emirate’s vision of building a unique global biobanking hub delivering invaluable data assets for maximal impact on people’s health. It aims to become a key pillar of health transformation, creating a diverse, foundational, bio-asset that supports therapeutic treatments, life science research for medical innovation, novel drug discovery targets and disease prevention, to deliver the highest level of personalised, precise, and preventative healthcare.

The service will be introduced across four leading healthcare entities committed to maternal and child health across the emirate. Prospective parents can avail themselves of this service at Danat Al Emarat Hospital for Women and Children, part of the M42 group, Corniche Hospital, Kanad Hospital, and hospitals as part of NMC Healthcare.

Her Excellency Dr Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi (DoH), said: “The launch of the Abu Dhabi Biobank is poised to deliver biobanking excellence across the region. The wealth of biological and medical data amassed by the Biobank will serve as a catalyst for scientific breakthroughs, expediting drug discovery, thus contributing to the emirate’s ability to find solutions for local and global health challenges. It will significantly impact clinical care and patient outcomes, with emphasis on cord-derived stem cell therapies and enable the delivery of local stem cell therapy. The Abu Dhabi Biobank’s ability to link cord blood, tissue, stem cells, and a wide range of normal and pathological human specimens with established large genomic, proteomics and clinical records, sets the scene for transformative and cutting-edge initiatives. Promising advancements in life sciences, this initiative further solidifies the emirate’s position as an attractive destination for global health-tech giants, researchers and investors to collaborate and spearhead healthcare innovations.”

The cord blood bank of Abu Dhabi Biobank aims to enable better care outcomes, build the nation’s self-sufficiency in meeting the urgent need for cord blood stem cells, and further enhance regional capabilities in research and innovation. Stem cells help to heal, restore, and replenish other cells that can be used in the treatment of certain haematological and immune system disorders, including leukaemia, lymphoma and bone marrow diseases requiring a transplant.

With a capacity to store 100,000 cord blood samples and five million pan human samples, the biobank aims to create a rich diverse dataset that can provide ready and better matched hemopoietic stem cells globally.

The cord blood bank facility of Abu Dhabi Biobank, situated in M42’s Omics Centre of Excellence, is equipped with automated technology and biobanking infrastructure that will preserve samples safely and securely, thereby making it viable for research and therapeutic use for 30 years.

Ashish Koshy, Group Chief Operating Officer, M42, said: “M42 is committed to advancing health by delivering the highest level of personalised, precise, and preventative health solutions for all. The Abu Dhabi Biobank will foster global innovation in therapy development, as it holds huge potential for regenerative medicine, aiding in rare disease treatment, genetic screening, early detection, and scientific research. We're proud to partner with the Department of Health – Abu Dhabi on this initiative, and we look forward to collaborating with them and other healthcare providers to drive progress in health and reinforce Abu Dhabi’s position as a global life science hub.”

The cord blood bank locally collects and preserves umbilical cord cells, offering donors the choice of preserving a newborn’s stem cells at birth, for potentially lifesaving treatments. Expectant mothers can preserve their baby’s cord blood and have the opportunity to preserve the stem cells as part of public or private banking.

More on this Topic

Under the patronage of Khaled bin Mohamed bin Zayed, inaugural of Abu Dhabi Global Healthcare Week to take place

Department of Health – Abu Dhabi partners with Eli Lilly and World Obesity Federation

Department of Health – Abu Dhabi elevating maternity services in emirate

Department of Health – Abu Dhabi honours healthcare facilities for exceeding Emiratisation targets

Related stories.

Khaled bin Mohamed bin Zayed inaugurates 1st Abu Dhabi Global Healthcare Week

M42 receives Global Healthcare Accreditation Certification for Excellence in Medical Travel Patient Experience

Rulers of Ajman, Umm Al Qaiwain, Sheikhs offer condolences on death of Hazza bin Sultan bin Zayed

• Terms & Conditions
• Privacy Policy

• Today's news
• Reviews and deals
• Climate change
• 2024 election
• Fall allergies
• Health news
• Mental health
• Sexual health
• Family health
• So mini ways
• Unapologetically
• Buying guides

Entertainment

• How to Watch
• My Portfolio
• Latest News
• Stock Market
• Premium News
• Biden Economy
• EV Deep Dive
• Stocks: Most Actives
• Stocks: Gainers
• Stocks: Losers
• Trending Tickers
• World Indices
• US Treasury Bonds
• Top Mutual Funds
• Highest Open Interest
• Highest Implied Volatility
• Stock Comparison
• Advanced Charts
• Currency Converter
• Basic Materials
• Communication Services
• Consumer Cyclical
• Consumer Defensive
• Financial Services
• Industrials
• Real Estate
• Mutual Funds
• Credit cards
• Balance Transfer Cards
• Cash-back Cards
• Rewards Cards
• Travel Cards
• Personal Loans
• Student Loans
• Car Insurance
• Morning Brief
• Market Domination
• Market Domination Overtime
• Opening Bid
• Stocks in Translation
• Lead This Way
• Good Buy or Goodbye?
• Fantasy football
• Pro Pick 'Em
• College Pick 'Em
• Fantasy baseball
• Fantasy hockey
• Fantasy basketball
• Download the app
• Daily fantasy
• Scores and schedules
• GameChannel
• World Baseball Classic
• Premier League
• CONCACAF League
• Champions League
• Motorsports
• Horse racing
• Newsletters

New on Yahoo

• Privacy Dashboard

Yahoo Finance

Department of health - abu dhabi partners with mbzuai and core42 to launch global ai healthcare academy.

ABU DHABI , UAE , May 13, 2024 /PRNewswire/ -- The  Department of Health – Abu Dhabi  (DoH), the regulator of the healthcare sector in the Emirate, signed a Memorandum of Understanding (MoU) with Mohamed bin Zayed University of Artificial Intelligence (MBZUAI), the leading AI research-based academic institution located in Abu Dhabi , and Core42, a G42 company offering AI solutions, during Abu Dhabi Global Healthcare Week (ADGHW). This MoU will launch the global AI Healthcare Academy to the health workforce. The MoU was signed by Dr. Rashed Obaid Al Suwaidi , Executive Director of Healthcare Workforce Planning Sector at DoH, Sultan Al Hajji , Vice President of Public Affairs and Alumni Relations at MBZUAI and Talal Al Kaissi , Executive Vice President, Chief Product and Global Partnership Officer at Core42.

Reinforcing Abu Dhabi's position as a leading destination for healthcare and life sciences, the partnership seeks to establish a framework of collaboration to strengthen the Emirate's position at the forefront of technology-enabled and data-driven healthcare systems. The new AI Healthcare Academy will help to build a global AI-trained workforce, which is capable of advancing diagnostic and operational efficiency, significantly improving patient care, and streamlining healthcare processes around the world.

Sultan Al Hajji , Vice President of Public Affairs and Alumni Relations at MBZUAI, said :  "Healthcare is a key research pillar for MBZUAI, because we recognise the transformative and life-saving potential of AI across a wide range of diagnostic and treatment areas. In addition to our recent effort in establishing the Institute of Digital Public Health, we are proud to partner with The Department of Health – Abu Dhabi in launching the new AI Healthcare Academy. MBZUAI will provide the Academy our world-class faculty to facilitate AI workshops and training to upskill the healthcare workforce in support of the UAE leadership's vision to become a global hub for AI and a centre for life sciences."

Through leveraging advanced technologies and harnessing the power of AI, DoH seeks to upskill the health workforce, enhance local practices and contribute to broader medical research and treatment modalities worldwide. By embracing AI-driven technologies, healthcare professionals can stay at the forefront of innovation, fostering collaboration and knowledge exchange on a global scale.

By collaborating with MBZUAI through its Institute of Digital Public Health, the Academy will encompass ground-breaking research. These efforts will encourage public-private partnerships, fostering collaboration to secure ample funding and ensure ongoing sustainability, setting the academy for long-term success and supporting responsible and impactful innovation.

Under the patronage of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan , Crown Prince of Abu Dhabi and Chairman of Abu Dhabi Executive Council, Abu Dhabi Global Healthcare Week (ADGHW) is a major government initiative from DoH, taking place between 13 and 15 May 2024 .

For more information please visit: https://www.adghw.com/

About Department of Health – Abu Dhabi (DoH):

The DoH is the regulatory body of the healthcare sector at the Emirate of Abu Dhabi and ensures excellence in healthcare by monitoring the health status of the population. DoH defines the strategy for the health system, monitors and analyses the health status of the population and performance of the system. In addition, DoH shapes the regulatory framework for the health system, inspects against regulations, enforce standards, and encourages adoption of world-class best practices and performance targets by all healthcare service providers in the Emirate. DoH also drives programmes to increase awareness and adoption of healthy living standards among the residents of the Emirate of Abu Dhabi in addition to regulating scope of services, premiums and reimbursement rates of the health system.

For further information on DoH, visit  https://www.doh.gov.ae/ and follow on X ,  Instagram ,  Facebook ,  LinkedIn and  YouTube .

About Mohamed bin Zayed University of Artificial Intelligence (MBZUAI)

MBZUAI is a graduate, research university focused on artificial intelligence, computer science, and digital technologies across industrial sectors. The university aims to empower students, businesses, and governments to advance artificial intelligence as a global force for positive progress. MBZUAI offers various graduate programs designed to pursue advanced, specialized knowledge and skills in artificial intelligence, including computer science, computer vision, machine learning, natural language processing, and robotics. For more information, please visit   www.mbzuai.ac.ae .

Photo - https://mma.prnewswire.com/media/2411164/The_Department_of_Health_Abu_Dhabi.jpg

View original content to download multimedia: https://www.prnewswire.com/news-releases/department-of-health--abu-dhabi-partners-with-mbzuai-and-core42-to-launch-global-ai-healthcare-academy-302143709.html

SOURCE The Department of Health - Abu Dhabi

Khaled bin Mohamed bin Zayed inaugurates 1st Abu Dhabi Global Healthcare Week

A BU DHABI, 13th May, 2024 (WAM) -- H.H. Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of Abu Dhabi Executive Council, has inaugurated the first edition of Abu Dhabi Global Healthcare Week (ADGHW) , organised by the Department of Health – Abu Dhabi under the theme ‘Accelerating the Future of Global Healthcare’, and taking place at Abu Dhabi National Exhibition Centre (ADNEC) until 15th May.

During a tour of the exhibition, H.H. Sheikh Khaled was briefed on the latest innovations in healthcare technologies and developments in medical sciences being showcased by healthcare institutions and companies. The event is expected to attract 5,000 participants, including 1,000 delegates from participating countries, 100 exhibitors, and more than 250 expert speakers from around the world, who have gathered to exchange insights and discuss the latest scientific trends and technological initiatives in healthcare, including disease diagnostic systems, pharmaceutical manufacturing projects, and the development of genomics and hereditary disease research, among other areas.

H.H. Sheikh Khaled highlighted that the UAE’s efforts in the healthcare sector, including launching several initiatives, innovative projects and programmes, reflect the leadership’s vision to provide advanced healthcare by accelerating research in medical and therapeutic fields, and by investing in strengthening healthcare infrastructure, including hospitals, healthcare facilities and specialised laboratories, to help further enhance the community’s health and quality of life.

He emphasised that organising this global event reflects Abu Dhabi’s commitment to supporting and encouraging investment in research and development in healthcare and life sciences by reinforcing cooperation and strategic partnerships between the public and private sectors to accelerate the transition to a preventive healthcare ecosystem that uses the most advanced innovations, while further strengthening Abu Dhabi’s position as a leading global healthcare hub that attracts innovation and global talent.

Abu Dhabi Global Healthcare Week serves as a platform for dialogue and knowledge exchange about future healthcare needs and the transition to a proactive and preventive healthcare approach. The event aims to enhance collaborative action to develop results-oriented healthcare ecosystems that rely on sustainable and innovative infrastructure, designed to adapt to changing needs.

During its first day, the event is hosting the Healthcare Leaders Forum, which will welcome around 200 VIPs including ministers and public officials, CEOs, international investors, heads of multilateral organisations, and leading health and medicine experts, to discuss ways of taking action to address current challenges in global healthcare. The results and recommendations of the forum will serve as a foundation for developing future strategic healthcare plans.

The three-day Future Health Summit will host a wide variety of panel sessions and live discussions around themes central to healthcare, including the use of AI in medical research, human longevity research, genomics, biotechnology, and pharmaceuticals, among other themes.

Sheikh Khaled was accompanied by H.H. Sheikh Theyab bin Mohamed bin Zayed Al Nahyan, Deputy Chairman of the Presidential Court for Development and Fallen Heroes' Affairs; Abdullah bin Sultan bin Awad Al Nuaimi, Minister of Justice; Dr. Thani bin Ahmed Al Zeyoudi, Minister of State for Foreign Trade; Dr. Mugheer Khamis Al Khaili, Chairman of the Department of Community Development; Sara Awadh Musallam, Chairwoman of Abu Dhabi Department of Education and Knowledge; Ahmed Jasim Al Zaabi, Chairman of the Abu Dhabi Department of Economic Development; Mansoor Ibrahim Al Mansoori, Chairman of the Department of Health - Abu Dhabi; Ahmed Tamim Al Kuttab, Chairman of the Department of Government Enablement; and Saif Saeed Ghobash, Secretary-General of the Abu Dhabi Executive Council.